Obesity
📧 Sign up to get email alerts when something new happens for Obesity.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-05-04FDA Approved: CONTRAVE EXTENDED-RELEASE — Supplemental Application (Nalpropion Pharmaceuticals LLC)
FDA approved a supplemental application to add CONTRAVE EXTENDED-RELEASE (naltrexone hydrochloride and bupropion hydrochloride) from Nalprop…
-
FDA approval · 2017-04-26FDA Approved: SAXENDA — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for SAXENDA (liraglutide) filed by Novo Nordisk. The approval indicates changes to the product's lab…
-
FDA approval · 2017-04-25FDA Approved: LIRAGLUTIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for liraglutide submitted by Teva Pharmaceuticals USA, Inc. The approval updates the product’s label…
-
FDA approval · 2017-03-17FDA Approved: PHENTERMINE HYDROCHLORIDE — Original Application (KVK-TECH, Inc.)
FDA approved an Original Application for phentermine hydrochloride from KVK-Tech, Inc., a generic version of the weight-management drug.
-
FDA approval · 2017-03-10FDA Approved: CONTRAVE EXTENDED-RELEASE — Supplemental Application (Nalpropion Pharmaceuticals LLC)
The FDA approved a supplemental application for CONTRAVE EXTENDED-RELEASE (naltrexone hydrochloride and bupropion hydrochloride) submitted b…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-01-27FDA Approved: PHENTERMINE AND TOPIRAMATE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application from Prasco Laboratories for phentermine and topiramate, enabling a generic version of the weigh…
-
FDA approval · 2017-01-27FDA Approved: CONTRAVE EXTENDED-RELEASE — Supplemental Application (Nalpropion Pharmaceuticals LLC)
The FDA approved a supplemental application for CONTRAVE EXTENDED-RELEASE (naltrexone hydrochloride and bupropion hydrochloride) from Nalpro…
-
FDA approval · 2017-01-06FDA Approved: CONTRAVE EXTENDED-RELEASE — Supplemental Application (Nalpropion Pharmaceuticals LLC)
FDA has approved a supplemental application for CONTRAVE EXTENDED-RELEASE (naltrexone hydrochloride and bupropion hydrochloride) filed by Na…
-
FDA approval · 2016-11-18FDA Approved: PHENTERMINE HYDROCHLORIDE — Original Application (POLYGEN PHARMACEUTICALS INC.)
FDA approved a generic phentermine hydrochloride product from Polygen Pharmaceuticals Inc., under an original Abbreviated New Drug Applicati…
-
FDA approval · 2016-11-09FDA Approved: PHENTERMINE — Original Application (Aurolife Pharma, LLC)
FDA approves Aurolife Pharma's phentermine hydrochloride generic for obesity as an approved generic product under an ANDA. This creates anot…
-
FDA approval · 2016-09-20FDA Approved: LIRAGLUTIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for liraglutide by Teva Pharmaceuticals USA, Inc., indicating an approved modification to the produc…
-
FDA approval · 2016-09-12FDA Approved: LOMAIRA — Original Application (KVK-TECH, INC.)
FDA approved LOMAIRA (phentermine hydrochloride) as an original application for a generic product by KVK-Tech, Inc.
-
FDA approval · 2016-08-12FDA Approved: XENICAL — Supplemental Application (H2-Pharma LLC)
FDA approved a supplemental application for Xenical (orlistat) submitted by H2-Pharma LLC.
-
FDA approval · 2016-05-25FDA Approved: ALLI — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for ALLI (orlistat) submitted by Haleon US Holdings LLC.
-
FDA approval · 2016-04-22FDA Approved: LIRAGLUTIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for liraglutide filed by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2015-12-15FDA Approved: BENZPHETAMINE HYDROCHLORIDE — Original Application (Epic Pharma, LLC)
The FDA approved the original application for benzphetamine hydrochloride from Epic Pharma, LLC, marking market approval for this prescripti…
-
FDA approval · 2015-11-17FDA Approved: METHAMPHETAMINE HYDROCHLORIDE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approves Hikma Pharmaceuticals USA Inc.'s generic methamphetamine hydrochloride tablets under an original ANDA; indications include atte…
-
FDA approval · 2015-08-07FDA Approved: XENICAL — Supplemental Application (H2-Pharma LLC)
FDA approved a supplemental application for Xenical (Orlistat) submitted by H2-Pharma LLC.
-
FDA approval · 2015-06-08FDA Approved: CONTRAVE EXTENDED-RELEASE — Supplemental Application (Nalpropion Pharmaceuticals LLC)
The FDA approved a supplemental application for CONTRAVE Extended-Release (naltrexone hydrochloride and bupropion hydrochloride) from Nalpro…
-
FDA approval · 2015-03-16FDA Approved: CONTRAVE EXTENDED-RELEASE — Supplemental Application (Nalpropion Pharmaceuticals LLC)
FDA approved a supplemental application for CONTRAVE EXTENDED-RELEASE (naltrexone hydrochloride and bupropion hydrochloride) by Nalpropion P…
-
FDA approval · 2015-03-09FDA Approved: LIRAGLUTIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for liraglutide from Teva Pharmaceuticals USA, Inc. The action indicates regulatory approval for pot…
-
FDA approval · 2015-02-25FDA Approved: LIRAGLUTIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for liraglutide (NDA 022341).
-
EMA approval · 2015-01-23Saxenda recommended for approval in weight management in adults
The EMA recommended granting approval for Saxenda for weight management in adults, marking its potential entry as a treatment option for obe…
-
FDA approval · 2014-12-23FDA Approved: SAXENDA — Original Application (Novo Nordisk)
FDA approved Saxenda (liraglutide) for the original indication of chronic weight management in adults. This approval established liraglutide…
-
FDA approval · 2014-12-05FDA Approved: PHENTERMINE HYDROCHLORIDE — Original Application (SUNRISE PHARMACEUTICAL, INC.)
FDA approves Sunrise Pharmaceutical's phentermine hydrochloride as an original-application generic, expanding access to the obesity manageme…